BioSpace News Archive

Eiger BioPharmaceuticals, Inc. reported that the Compensation Committee of Eiger’s Board of Directors granted stock options to purchase an aggregate of 290,000 shares of Eiger’s common stock to two newly hired employees.

Procaps Group S.A., a leading integrated LatAm healthcare and pharmaceutical conglomerate, announced its financial results for the fourth quarter and fiscal year ended December 31, 2021.

Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company”), a clinical-stage macrophage reprogramming immunotherapy company, today announced its full year 2021 financial results, the completion of development of a frozen formulation of Allocetra™ twelve months ahead of schedule, and provided strategic updates on its clinical programs.

NEOGEN Corporation (NASDAQ: NEOG) and FOXO Technologies, Inc. (“FOXO”) — a technology company applying epigenetic science and AI to modernize the life insurance industry — collaborated on an extensive research project examining the association between epigenetic aging and numerous behavioral, lifestyle, dietary and clinical risk factors, as well as major morbidity and mortality outcomes.

Neovasc Inc. (NASDAQ , TSX : NVCN), will report financial results for the quarter ended March 31, 2022 on Thursday, May 12, 2022.

Abeona Therapeutics Inc. (Nasdaq: ABEO), a fully-integrated leader in cell and gene therapy, today announced that preclinical data on AAV204, a novel adeno-associated virus (AAV) capsid from Abeona’s in-licensed AIM™ capsid library, will be presented at the Association for Research and Vision in Ophthalmology (ARVO) Annual Meeting.

Representatives of Rafarma Pharmaceuticals, Inc. visited Uzbekistan and discussed the prospects for the company’s development in the territory of the innovative research and production pharmaceutical cluster “Tashkent Pharma Park”.

Lyra Therapeutics, Inc. (Nasdaq: LYRA), today is presenting additional, new data from its LANTERN Phase 2 study of LYR-210 in adult patients with chronic rhinosinusitis (CRS) at the 2022 Combined Otolaryngology Spring Meetings (COSM) being held April 27 – May 1, 2022 in Dallas, Texas.

Global Immune Checkpoint Inhibitors Biomarkers & Clinical Trials Insight 2028 Report Highlights.

Global Cancer Antibody Drug Conjugate Market 2028 Report Highlights.